AppliedVR, an immersive therapeutics (ITx) pioneer advancing a novel, virtual reality-based approach to medicine, has announced a contract with the U.S. Department of Veterans Affairs (VA) to provide its FDA-authorized RelieVRx solution to select Veterans impacted by chronic lower back pain (CLBP).
It was awarded the contract with the VHA Innovation Ecosystem, a division of the VA that discovers, evaluates, and spreads mission-driven innovations that advance care delivery for Veterans.
As per reports, RelieVRx is the first and only FDA-authorized in-home immersive VR pain treatment indicated as an adjunctive treatment for CLBP. The eight-week program has been clinically demonstrated to decrease pain severity and pain interference in the lives of people experiencing CLBP. In a recent clinical trial follow-up study, the RelieVRx system also was shown to deliver durable effects six months after treatment.
Through this effort, healthcare providers at 18 VA facilities will have the ability to prescribe the RelieVRx program to veterans for use in their homes.
Join the HealthXL Masterclass on the ‘DTx Access Negotiation and Contracting with Commercial Health Plans in the US’ on 15th December. Click here to Request to Join.
Click here to read the original news article.